Summit Therapeutics Inc.

SMMTNASDAQHealthcare● Active

$14.52

$-0.26(-1.73%)

Market Cap$11.3B

P/E Ratio—

52W High$30.98

52W Low$13.83

Avg Volume4.1M

Open$14.94

Beta-1.31

Overview

Summit Therapeutics Inc.（SMMT）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · SMMT · 截至 2026年6月8日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

∞

Buy/Sell (by trades)

整体情绪

偏多

↑ Buy 100%仅显示有效交易 · 排除RSU归属0% Sell ↓

Summit Therapeutics Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

SMMT 季度内部人买卖趋势

SMMT 内幕交易卖出 · SMMT 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

50.0M25.0M0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · SMMT CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

SMMT 高管卖出股份 · SMMT 董事内幕交易 · SEC Form 4申报

显示最近 33 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Jun 4, 2026	DUGGAN ROBERT W Co-Chief Executive Officer · Director	Purchase	100,000	$14.60	$1.46M⚡	25,824,474	Form 4
Jun 4, 2026	Zanganeh Mahkam Co-Chief Executive Officer · Director	Purchase	100,000	$14.60	$1.46M⚡	25,824,474	Form 4
Jun 4, 2026	Soni Manmeet Singh COO and CFO · Director	Purchase	25,000	$14.43	$361K	3,123,603	Form 4
Jun 4, 2026	Soni Manmeet Singh COO and CFO · Director	Purchase	25,000	$14.46	$362K	3,098,603	Form 4
Oct 21, 2025	Xia Yu Director	Purchase	533,617	$18.74	$10.00M⚡	32,057,147	Form 4
Oct 21, 2025	Anand Bhaskar CAO	Award	26,680	$18.74	$500K	159,751	Form 4
Oct 21, 2025	Soni Manmeet Singh COO and CFO · Director	Award	53,361	$18.74	$1000K	3,073,603	Form 4
Oct 21, 2025	DUGGAN ROBERT W Co-Chief Executive Officer · Director	Award	13,980,789	$18.74	$262.00M⚡	570,073,879	Form 4
Oct 21, 2025	DUGGAN ROBERT W Co-Chief Executive Officer · Director	Award	266,808	$18.74	$5.00M⚡	25,724,474	Form 4
Oct 21, 2025	DUGGAN ROBERT W Co-Chief Executive Officer · Director	Purchase	26,680	$18.74	$500K	76,680	Form 4
Oct 21, 2025	Zanganeh Mahkam Co-Chief Executive Officer · Director	Award	13,980,789	$18.74	$262.00M⚡	570,073,879	Form 4
Oct 21, 2025	Zanganeh Mahkam Co-Chief Executive Officer · Director	Award	266,808	$18.74	$5.00M⚡	25,724,474	Form 4
Oct 21, 2025	Zanganeh Mahkam Co-Chief Executive Officer · Director	Purchase	26,680	$18.74	$500K	76,680	Form 4
Sep 11, 2025	Zanganeh Mahkam Co-Chief Executive Officer · Director	Purchase	5,000	$18.07	$90K	556,093,090	Form 4
Sep 10, 2025	Zanganeh Mahkam Co-Chief Executive Officer · Director	Purchase	333,394	$17.68	$5.89M⚡	556,088,090	Form 4
Sep 11, 2025	DUGGAN ROBERT W Co-Chief Executive Officer · Director	Purchase	5,000	$18.07	$90K	556,093,090	Form 4
Sep 10, 2025	DUGGAN ROBERT W Co-Chief Executive Officer · Director	Purchase	333,394	$17.68	$5.89M⚡	556,088,090	Form 4
May 30, 2025	Zanganeh Mahkam Co-Chief Executive Officer · Director	Option	74,545	$2.64	$197K	555,754,696	Form 4
May 30, 2025	DUGGAN ROBERT W Co-Chief Executive Officer · Director	Option	74,545	$2.64	$197K	555,754,696	Form 4
Apr 8, 2025	Zanganeh Mahkam Co-Chief Executive Officer · Director	Other	3,985,055	$1.58	$6.30M⚡	555,680,151	Form 4
Apr 8, 2025	DUGGAN ROBERT W Co-Chief Executive Officer · Director	Other	3,985,055	$1.58	$6.30M⚡	555,680,151	Form 4
Oct 3, 2024	Zanganeh Mahkam Co-Chief Executive Officer · Director	Other	315,681	$1.58	$499K	10,199,776	Form 4
Sep 11, 2024	Zanganeh Mahkam Co-Chief Executive Officer · Director	Award	44,052	$22.70	$1000K	24,967,852	Form 4
Sep 11, 2024	DUGGAN ROBERT W Co-Chief Executive Officer · Director	Award	3,325,991	$22.70	$75.50M⚡	551,695,096	Form 4
Sep 11, 2024	Huber Jeff Director	Award	44,052	$22.70	$1000K	44,052	Form 4

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Purchase

日期

Jun 4

股数

100,000

均价

$14.60

总金额

$1.46M ⚡

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Purchase

日期

Jun 4

股数

100,000

均价

$14.60

总金额

$1.46M ⚡

View Form 4 on SEC.gov

Soni Manmeet Singh

COO and CFO · Director

Purchase

日期

Jun 4

股数

25,000

均价

$14.43

总金额

$361K

View Form 4 on SEC.gov

Soni Manmeet Singh

COO and CFO · Director

Purchase

日期

Jun 4

股数

25,000

均价

$14.46

总金额

$362K

View Form 4 on SEC.gov

Xia Yu

Director

Purchase

日期

Oct 21

股数

533,617

均价

$18.74

总金额

$10.00M ⚡

View Form 4 on SEC.gov

Anand Bhaskar

CAO

Award

日期

Oct 21

股数

26,680

均价

$18.74

总金额

$500K

View Form 4 on SEC.gov

Soni Manmeet Singh

COO and CFO · Director

Award

日期

Oct 21

股数

53,361

均价

$18.74

总金额

$1000K

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Award

日期

Oct 21

股数

13,980,789

均价

$18.74

总金额

$262.00M ⚡

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Award

日期

Oct 21

股数

266,808

均价

$18.74

总金额

$5.00M ⚡

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Purchase

日期

Oct 21

股数

26,680

均价

$18.74

总金额

$500K

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Award

日期

Oct 21

股数

13,980,789

均价

$18.74

总金额

$262.00M ⚡

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Award

日期

Oct 21

股数

266,808

均价

$18.74

总金额

$5.00M ⚡

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Purchase

日期

Oct 21

股数

26,680

均价

$18.74

总金额

$500K

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Purchase

日期

Sep 11

股数

5,000

均价

$18.07

总金额

$90K

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Purchase

日期

Sep 10

股数

333,394

均价

$17.68

总金额

$5.89M ⚡

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Purchase

日期

Sep 11

股数

5,000

均价

$18.07

总金额

$90K

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Purchase

日期

Sep 10

股数

333,394

均价

$17.68

总金额

$5.89M ⚡

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Option

日期

May 30

股数

74,545

均价

$2.64

总金额

$197K

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Option

日期

May 30

股数

74,545

均价

$2.64

总金额

$197K

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Other

日期

Apr 8

股数

3,985,055

均价

$1.58

总金额

$6.30M ⚡

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Other

日期

Apr 8

股数

3,985,055

均价

$1.58

总金额

$6.30M ⚡

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Other

日期

Oct 3

股数

315,681

均价

$1.58

总金额

$499K

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Award

日期

Sep 11

股数

44,052

均价

$22.70

总金额

$1000K

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Award

日期

Sep 11

股数

3,325,991

均价

$22.70

总金额

$75.50M ⚡

View Form 4 on SEC.gov

Huber Jeff

Director

Award

日期

Sep 11

股数

44,052

均价

$22.70

总金额

$1000K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 2

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 SMMT 内幕交易

SMMT 内幕交易

Summit Therapeutics Inc.（SMMT）内幕交易数据来源于公司内部人（包括DUGGAN ROBERT W (Co-Chief Executive Officer · Director), Zanganeh Mahkam (Co-Chief Executive Officer · Director), Soni Manmeet Singh (COO and CFO · Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。SMMT内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Summit Therapeutics Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

SMMT 内幕交易 · 5个问题

Summit Therapeutics Inc.（SMMT）的内部人包括高管和董事，如DUGGAN ROBERT W (Co-Chief Executive Officer · Director), Zanganeh Mahkam (Co-Chief Executive Officer · Director), Soni Manmeet Singh (COO and CFO · Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

SMMT 董事内幕交易SMMT 内部人名单Summit Therapeutics Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026